HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Recognition and diagnosis of neuro-ichthyotic syndromes.

Abstract
The combination of neurologic disease and ichthyosis defines a heterogeneous group of rare inherited disorders that present in infancy through early adulthood. Although affected patients share the cutaneous feature of ichthyosis, there is variability in the nature and severity of neurologic disease. Impaired cognition, spasticity, sensorineural deafness, visual impairment, and/or seizures are the primary neurologic findings. Most of these disorders are caused by genetic defects in lipid metabolism, glycoprotein synthesis, or intracellular vesicle trafficking. The clinical features of some of the neuro-ichthyoses are distinct enough to allow their clinical recognition, but confirmatory biochemical or genetic tests are necessary for accurate diagnosis. Treatment of the ichthyosis is largely symptomatic, and except for Refsum's disease, there are no effective pathogenesis-based therapies for the neurologic disease.
AuthorsWilliam B Rizzo, Sabrina Malone Jenkens, Philip Boucher
JournalSeminars in neurology (Semin Neurol) Vol. 32 Issue 1 Pg. 75-84 (Feb 2012) ISSN: 1098-9021 [Electronic] United States
PMID22422210 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Review)
CopyrightThieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.
Topics
  • Humans
  • Ichthyosis (diagnosis, genetics)
  • Infant
  • Infant, Newborn
  • Lipid Metabolism
  • Mutation (genetics)
  • Skin (metabolism, physiopathology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: